SE7609813L - Triazolylbensofenonderivat - Google Patents

Triazolylbensofenonderivat

Info

Publication number
SE7609813L
SE7609813L SE7609813A SE7609813A SE7609813L SE 7609813 L SE7609813 L SE 7609813L SE 7609813 A SE7609813 A SE 7609813A SE 7609813 A SE7609813 A SE 7609813A SE 7609813 L SE7609813 L SE 7609813L
Authority
SE
Sweden
Prior art keywords
derivatives
triazolylbenzophene
formula
compounds
spasmolytics
Prior art date
Application number
SE7609813A
Other languages
English (en)
Swedish (sv)
Inventor
K Hirai
T Fujishita
T Ishiba
H Sugimoto
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of SE7609813L publication Critical patent/SE7609813L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/92—Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7609813A 1975-12-30 1976-09-06 Triazolylbensofenonderivat SE7609813L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
SE7609813L true SE7609813L (sv) 1977-07-01

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7609813A SE7609813L (sv) 1975-12-30 1976-09-06 Triazolylbensofenonderivat

Country Status (19)

Country Link
JP (1) JPS5283469A (ja)
AR (2) AR218613A1 (ja)
AT (1) AT350052B (ja)
AU (1) AU498113B2 (ja)
BE (1) BE846410A (ja)
CA (1) CA1126274A (ja)
CH (1) CH623315A5 (ja)
DE (1) DE2641164A1 (ja)
DK (1) DK393576A (ja)
ES (3) ES451896A1 (ja)
FR (1) FR2336930A1 (ja)
GB (1) GB1531980A (ja)
HU (1) HU172539B (ja)
IE (1) IE43841B1 (ja)
IL (1) IL50664A (ja)
NL (1) NL7610799A (ja)
NZ (1) NZ181958A (ja)
SE (1) SE7609813L (ja)
ZA (1) ZA765851B (ja)

Also Published As

Publication number Publication date
AR218613A1 (es) 1980-06-30
DK393576A (da) 1977-07-01
HU172539B (hu) 1978-09-28
IL50664A (en) 1983-09-30
AT350052B (de) 1979-05-10
AU498113B2 (en) 1979-02-08
ES462244A1 (es) 1978-06-01
IE43841B1 (en) 1981-06-03
FR2336930A1 (fr) 1977-07-29
ES451896A1 (es) 1978-01-16
AR220519A1 (es) 1980-11-14
CA1126274A (en) 1982-06-22
AU1749876A (en) 1978-03-16
ES462243A1 (es) 1978-06-01
DE2641164A1 (de) 1977-07-14
CH623315A5 (en) 1981-05-29
FR2336930B1 (ja) 1978-12-22
NL7610799A (nl) 1977-07-04
JPS5283469A (en) 1977-07-12
IE43841L (en) 1977-06-30
ZA765851B (en) 1977-09-28
BE846410A (fr) 1977-01-17
ATA684276A (de) 1978-10-15
GB1531980A (en) 1978-11-15
NZ181958A (en) 1979-03-28
IL50664A0 (en) 1976-12-31

Similar Documents

Publication Publication Date Title
SE7406513L (sv) Gastrinsyrasekretionsmedel.
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
ES8402262A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ES448588A1 (es) Un procedimiento para la preparacion de un compuesto hetero-arilico.
ES425514A1 (es) Un procedimiento para la preparacion de nuevas 3-nitrocuma-rinas.
SE7604093L (sv) Anorexa foreningar
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
IL47769A (en) 2-((4-alkyl-1-piperazinyl)-methyl)-1-benzyl benzimidazole derivatives, their manufacture and pharmaceutical compositions containing the same
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
IT1141135B (it) Derivati peptidici,procedimento per prepararli e relative composizioni farmaceutiche
FI65616B (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara 1-oxadiazolylfenoxi-3-(4-fenylpiperazinyl)-propanol-2-derivat
SE7609813L (sv) Triazolylbensofenonderivat
FR2446279A1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
ATE1352T1 (de) Phenylalanyltryptophan-derivate, sie enthaltende arzneimittel, ihre herstellung und verwendung.
ES419439A1 (es) Procedimiento para la preparacion de nuevos derivados de carbamoil-sulfoxido.
ES424946A1 (es) Procedimiento para la preparacion de derivados de imidazol.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ES430676A1 (es) Procedimiento para la preparacion de 1,2,4-tiadiazolo- (2,3-a) bencimidazoles-2-sustituidos.
BE802006Q (fr) Stabilisation de compositions polymere par la 3'
NL7512384A (nl) Werkwijze voor het bereiden van 10.11-dihydro 3-carboxycyproheptadinen.
BE789189A (fr) Perfectionnements aux procedes de preparation, de depyrogenation et de stabilisation de l'urokinase et compositions obtenues
SE7509607L (sv) Forfarnde for framstellning av 9,11,15-trihydroxi-13,14-dehydroprostaglandiner och prost-5-en-13-ynsyraderivat
GR35526B (el) Μεθοδος παρασκευης ετεροκυκλικων ενωσεων αζωτου.
SE7409378L (ja)
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7609813-6